Physician profile
John Salerno
NPI 1285746669
$2,796.89
in general payments reported to CMS, 2019-2025
18 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $245 · 2021: $16.29 · 2022: $26.12 · 2023: $386 · 2024: $1,768 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,348.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $1,364.85 | 2023-2024 | Novosorb Btm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $386.73 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $290.60 | 2019-2024 | Mounjaro, Zepbound |
| Romark Laboratories, Lc | $139.56 | 2020 | |
| Acella Pharmaceuticals, LLC | $124.35 | 2024-2025 | NP Thyroid 60 |
| Antares Pharma, INC. | $103.11 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Takeda Pharmaceuticals U.S.A., INC. | $74.62 | 2024-2025 | Hyqvia |
| Halozyme INC | $47.06 | 2023 | |
| Endo Pharmaceuticals INC. | $41.06 | 2020 | |
| Alk-Abello, INC | $32.06 | 2024 | Odactra, Grastek, Ragwitek |
| Phadia US INC. | $30.90 | 2021-2024 | Immunocap |
| Genentech USA, INC. | $26.12 | 2022 | |
| Ani Pharmaceuticals, INC. | $25.74 | 2024 | Purified Cortrophin Gel |
| Csl Behring | $23.84 | 2025 | Hizentra |
| Avion Pharmaceuticals | $23.66 | 2024 | NP Thyroid 60 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.95 | 2020 | |
| Exact Sciences Corporation | $21.27 | 2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $18.41 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Salerno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.